• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉非替尼和姜黄素载药纳米粒增强人口腔癌细胞 SAS 体外细胞凋亡并抑制 SAS 细胞异种移植瘤体内生长。

Gefitinib and curcumin-loaded nanoparticles enhance cell apoptosis in human oral cancer SAS cells in vitro and inhibit SAS cell xenografted tumor in vivo.

机构信息

Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, Tainan, Taiwan; Department of Surgery, China Medical University Beigang Hospital, Beigang, Yunlin, Taiwan.

Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.

出版信息

Toxicol Appl Pharmacol. 2019 Nov 1;382:114734. doi: 10.1016/j.taap.2019.114734. Epub 2019 Aug 27.

DOI:10.1016/j.taap.2019.114734
PMID:31470033
Abstract

Curcumin (Cur), a natural product, has been shown to have anti-tumor activities in many human cancer cells. Gefitinib (Gef) is a clinical drug for cancer patients. However, there is no available information to show whether Gef/Cur nanoparticles (NPs) increased cell apoptosis and anti-tumor effects on xenograft mice model in vivo. In this study, γ-polyglutamic acid-coated nanoparticles loaded with Gef and Cur (γ-PGA-Gef/Cur NPs) were developed and its physicochemical properties and antitumor effects were investigated in vitro and in vivo. The γ-PGA-Gef/Cur NPs showed 548.5 ± 93.7 nm in diameter and -40.3 ± 3.87 mV on surface charge. The loading efficiencies of Gef and Cur were 89.5 and 100%, respectively. γ-PGA-Gef/Cur NPs could be internalized into SAS cells and significantly decreased total cell viability of SAS cells. Western blotting results indicated that both free Gef/Cur and γ-PGA-Gef/Cur NPs induced apoptotic cell death via caspase- and mitochondria-dependent pathways. In vivo studies indicated that treatments of PLGA NPs, free Gef/Cur, and γ-PGA-Gef/Cur NPs did not significantly affect appearances and bodyweights of mice. But the γ-PGA-Gef/Cur NPs significantly suppressed tumor size when comparing to free Gef/Cur-treated group. The nanoparticles developed in this study may be used as a potential therapy for oral cancer.

摘要

姜黄素(Cur)是一种天然产物,已在许多人类癌细胞中显示出抗肿瘤活性。吉非替尼(Gef)是一种癌症患者的临床药物。然而,没有可用的信息表明 Gef/Cur 纳米颗粒(NPs)是否在体内异种移植小鼠模型中增加细胞凋亡和抗肿瘤作用。在这项研究中,开发了 γ-聚谷氨酸(γ-PGA)包裹的载有 Gef 和 Cur 的纳米颗粒(γ-PGA-Gef/Cur NPs),并在体外和体内研究了其理化性质和抗肿瘤作用。γ-PGA-Gef/Cur NPs 的直径为 548.5±93.7nm,表面电荷为-40.3±3.87mV。Gef 和 Cur 的载药效率分别为 89.5%和 100%。γ-PGA-Gef/Cur NPs 可以被 SAS 细胞内化,并显著降低 SAS 细胞的总细胞活力。Western blot 结果表明,游离 Gef/Cur 和 γ-PGA-Gef/Cur NPs 均可通过 caspase 和线粒体依赖性途径诱导细胞凋亡。体内研究表明,PLGA NPs、游离 Gef/Cur 和 γ-PGA-Gef/Cur NPs 处理均未显著影响小鼠的外观和体重。但与游离 Gef/Cur 处理组相比,γ-PGA-Gef/Cur NPs 显著抑制了肿瘤大小。本研究开发的纳米颗粒可作为口腔癌的潜在治疗方法。

相似文献

1
Gefitinib and curcumin-loaded nanoparticles enhance cell apoptosis in human oral cancer SAS cells in vitro and inhibit SAS cell xenografted tumor in vivo.吉非替尼和姜黄素载药纳米粒增强人口腔癌细胞 SAS 体外细胞凋亡并抑制 SAS 细胞异种移植瘤体内生长。
Toxicol Appl Pharmacol. 2019 Nov 1;382:114734. doi: 10.1016/j.taap.2019.114734. Epub 2019 Aug 27.
2
Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.载姜黄素纳米粒通过调节多药耐药 1 功能和活性氧诱导顺铂耐药 CAR 人舌鳞癌细胞凋亡。
Int J Oncol. 2013 Oct;43(4):1141-50. doi: 10.3892/ijo.2013.2050. Epub 2013 Aug 5.
3
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.姜黄素负载纳米颗粒在前列腺癌中的抗癌活性
Biomaterials. 2014 Oct;35(30):8635-48. doi: 10.1016/j.biomaterials.2014.06.040. Epub 2014 Jul 12.
4
Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.使用多柔比星和姜黄素联合治疗肺癌:基于靶向前药、pH 敏感的纳米药物。
Biomed Pharmacother. 2019 Apr;112:108614. doi: 10.1016/j.biopha.2019.108614. Epub 2019 Feb 21.
5
Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway.载姜黄素纳米粒通过 Akt-Bad 信号通路增强 U2OS 人骨肉瘤细胞的凋亡性细胞死亡。
Int J Oncol. 2014 Jan;44(1):238-46. doi: 10.3892/ijo.2013.2175. Epub 2013 Nov 14.
6
Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.转铁蛋白靶向纳米颗粒共递送阿霉素和pH敏感姜黄素前药用于乳腺癌治疗
Oncol Rep. 2017 Feb;37(2):1253-1260. doi: 10.3892/or.2017.5345. Epub 2017 Jan 2.
7
Curcumin-loaded PLGA nanoparticles conjugated with anti- P-glycoprotein antibody to overcome multidrug resistance.负载姜黄素的聚乳酸-羟基乙酸共聚物纳米粒与抗P-糖蛋白抗体偶联以克服多药耐药性。
Asian Pac J Cancer Prev. 2014;15(21):9249-58. doi: 10.7314/apjcp.2014.15.21.9249.
8
A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.基于载姜黄素β-环糊精纳米粒的新型叶酸受体靶向给药系统用于癌症治疗。
Drug Des Devel Ther. 2021 Jun 30;15:2843-2855. doi: 10.2147/DDDT.S320119. eCollection 2021.
9
Tunable pH and redox-responsive drug release from curcumin conjugated γ-polyglutamic acid nanoparticles in cancer microenvironment.在肿瘤微环境中,姜黄素偶联γ-聚谷氨酸纳米粒子的 pH 和氧化还原响应性药物释放。
Colloids Surf B Biointerfaces. 2017 Nov 1;159:809-819. doi: 10.1016/j.colsurfb.2017.08.057. Epub 2017 Aug 31.
10
Curcuminoids combined with gefitinib mediated apoptosis and autophagy of human oral cancer SAS cells in vitro and reduced tumor of SAS cell xenograft mice in vivo.姜黄素类化合物与吉非替尼联合在体外介导人口腔癌SAS细胞的凋亡和自噬,并在体内减少SAS细胞异种移植小鼠的肿瘤。
Environ Toxicol. 2018 May 2. doi: 10.1002/tox.22568.

引用本文的文献

1
Innovative nanoparticle strategies for treating oral cancers.治疗口腔癌的创新纳米颗粒策略。
Med Oncol. 2025 Apr 26;42(6):182. doi: 10.1007/s12032-025-02728-y.
2
Cytotoxicity of Nanocarrier-Based Drug Delivery in Oral Cancer Therapy: A Systematic Review and Meta-Analysis.基于纳米载体的药物递送在口腔癌治疗中的细胞毒性:一项系统评价和荟萃分析
Cancer Control. 2025 Jan-Dec;32:10732748241310936. doi: 10.1177/10732748241310936.
3
Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors.
推动小分子酪氨酸激酶抑制剂纳米制剂的生物制药和药代动力学特性。
Asian J Pharm Sci. 2024 Dec;19(6):100980. doi: 10.1016/j.ajps.2024.100980. Epub 2024 Oct 26.
4
The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review.姜黄素治疗放疗和化疗相关口腔黏膜炎的有效性:一项系统评价
Antioxidants (Basel). 2024 Sep 25;13(10):1160. doi: 10.3390/antiox13101160.
5
Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective.口腔癌治疗中的纳米药物递送系统:最新进展与展望
Pharmaceutics. 2023 Dec 19;16(1):7. doi: 10.3390/pharmaceutics16010007.
6
On chip synthesis of a pH sensitive gefitinib anticancer drug nanocarrier based on chitosan/alginate natural polymers.基于壳聚糖/海藻酸钠天然聚合物的芯片合成 pH 敏感吉非替尼抗癌药物纳米载体。
Sci Rep. 2024 Jan 8;14(1):772. doi: 10.1038/s41598-024-51483-z.
7
Use in Maintaining Oral Health and Its Potential Use in Regenerative Dentistry.用于维持口腔健康及其在再生牙科中的潜在用途。
ScientificWorldJournal. 2023 Oct 17;2023:8876189. doi: 10.1155/2023/8876189. eCollection 2023.
8
Applications of Curcumin and Its Nanoforms in the Treatment of Cancer.姜黄素及其纳米形式在癌症治疗中的应用。
Pharmaceutics. 2023 Aug 29;15(9):2223. doi: 10.3390/pharmaceutics15092223.
9
Nanotechnology boosts the efficiency of tumor diagnosis and therapy.纳米技术提高了肿瘤诊断和治疗的效率。
Front Bioeng Biotechnol. 2023 Jul 28;11:1249875. doi: 10.3389/fbioe.2023.1249875. eCollection 2023.
10
Therapeutic potential of curcumin and its nanoformulations for treating oral cancer.姜黄素及其纳米制剂在治疗口腔癌方面的治疗潜力。
World J Methodol. 2023 Jun 20;13(3):29-45. doi: 10.5662/wjm.v13.i3.29.